Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP

Last updated on 2019-07-18 History
Report ID 78454
Drug Identification Number 02387468
Brand name LABETALOL HYDROCHLORIDE INJECTION, USP
Common or Proper name LABETALOL HYDROCHLORIDE INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML 1VL
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-07-17
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-07-18
Company comments ID 10718 was resolved in error on Mar-8-2019. Reopened in this ID.
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v38 2019-07-18 English Compare
v37 2019-07-16 French Compare
v36 2019-07-16 English Compare
v35 2019-07-11 English Compare
v34 2019-07-09 French Compare
v33 2019-07-09 English Compare
v32 2019-07-04 English Compare
v31 2019-07-03 French Compare
v30 2019-07-03 English Compare
v29 2019-06-29 English Compare
v28 2019-06-25 French Compare
v27 2019-06-25 English Compare
v26 2019-06-20 English Compare
v25 2019-06-18 French Compare
v24 2019-06-18 English Compare
v23 2019-06-06 English Compare
v22 2019-06-04 French Compare
v21 2019-06-04 English Compare
v20 2019-05-30 English Compare
v19 2019-05-28 French Compare

Showing 1 to 20 of 38